Literature DB >> 2448879

Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21.

A M de Vos1, L Tong, M V Milburn, P M Matias, J Jancarik, S Noguchi, S Nishimura, K Miura, E Ohtsuka, S H Kim.   

Abstract

The crystal structure at 2.7 A resolution of the normal human c-H-ras oncogene protein lacking a flexible carboxyl-terminal 18 residue reveals that the protein consists of a six-stranded beta sheet, four alpha helices, and nine connecting loops. Four loops are involved in interactions with bound guanosine diphosphate: one with the phosphates, another with the ribose, and two with the guanine base. Most of the transforming proteins (in vivo and in vitro) have single amino acid substitutions at one of a few key positions in three of these four loops plus one additional loop. The biological functions of the remaining five loops and other exposed regions are at present unknown. However, one loop corresponds to the binding site for a neutralizing monoclonal antibody and another to a putative "effector region"; mutations in the latter region do not alter guanine nucleotide binding or guanosine triphosphatase activity but they do reduce the transforming activity of activated proteins. The data provide a structural basis for understanding the known biochemical properties of normal as well as activated ras oncogene proteins and indicate additional regions in the molecule that may possibly participate in other cellular functions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448879     DOI: 10.1126/science.2448879

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  107 in total

1.  Interaction of GTPase-activating protein with p21ras, measured using a continuous assay for inorganic phosphate release.

Authors:  M R Webb; J L Hunter
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  An essential Saccharomyces cerevisiae gene homologous to SNF2 encodes a helicase-related protein in a new family.

Authors:  B C Laurent; X Yang; M Carlson
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

3.  The structure of the carboxyl terminus of the p21 protein. Structural relationship to the nucleotide-binding/transforming regions of the protein.

Authors:  P W Brandt-Rauf; R P Carty; J M Chen; G Lee; S Rackovsky; M R Pincus
Journal:  J Protein Chem       Date:  1990-04

4.  Interaction of the isolated domain II/III of Thermus thermophilus elongation factor Tu with the nucleotide exchange factor EF-Ts.

Authors:  M E Peter; C O Reiser; N K Schirmer; T Kiefhaber; G Ott; N W Grillenbeck; M Sprinzl
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

5.  Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line.

Authors:  G T Drivas; A Shih; E Coutavas; M G Rush; P D'Eustachio
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

6.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

Review 7.  Acylation of viral and eukaryotic proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

8.  Neuronal expression of a newly identified Drosophila melanogaster G protein alpha 0 subunit.

Authors:  C J Schmidt; S Garen-Fazio; Y K Chow; E J Neer
Journal:  Cell Regul       Date:  1989-11

9.  Active site labelling of inositol 1,4,5-trisphosphate 3-kinase A by phenylglyoxal.

Authors:  D Communi; R Lecocq; V Vanweyenberg; C Erneux
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

10.  Selenomethionine incorporation into a protein by cell-free synthesis.

Authors:  Takanori Kigawa; Emi Yamaguchi-Nunokawa; Koichiro Kodama; Takayoshi Matsuda; Takashi Yabuki; Natsuko Matsuda; Ryuichiro Ishitani; Osamu Nureki; Shigeyuki Yokoyama
Journal:  J Struct Funct Genomics       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.